Drugs / Oxepa
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01162928 | May 2013 → Nov 2017 | — | B. Braun Melsungen AG | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxepa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01162928 ↗ |